DNLI FY 2017 Earnings — Denali Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

DNLIDenali Therapeutics Inc.

$3B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$90M

Net Income

-$88M

EPS (Diluted)

$-5.89

Cash Flow

Operating Cash Flow

-$77M

Free Cash Flow

-$80M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$487M

Total Liabilities

$21M

Stockholders' Equity

$466M

Cash & Equivalents

$218M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	-$1M	-109.8%
Operating Income	-$90M	-$87M	-3.1%
Net Income	-$88M	-$87M	-1.8%